European cystic fibrosis bone mineralisation guidelines
Abstract
Patients with cystic fibrosis (CF) are at risk of developing low bone mineral density (BMD) and fragility fractures. This paper presents consensus statements that summarise current knowledge of the epidemiology and pathophysiology of CF-related skeletal deficits and provides guidance on its assessment, prevention and treatment. The statements were validated using a modified Delphi methodology.
Keywords: Cystic fibrosis , Dual Energy X-ray Absorptiometry (DXA) , Bone density , Fractures , Bisphosphonates , Calcium , Vitamin D , Puberty
No full text is available. To read the body of this article, please view the PDF online.
To access this article, please choose from the options below
PII: S1569-1993(11)60004-0
doi:10.1016/S1569-1993(11)60004-0
© 2011 European Cystic Fibrosis Society. Published by Elsevier Inc. All rights reserved.
